PGIMER's Ravindra Khaiwal named among world's top researchers
1
2
3
Chandigarh:
Ravindra Khaiwal
, a distinguished faculty member from the department of community medicine and School of Public Health at the Postgraduate Institute of Medical Education and Research (
PGIMER
), Chandigarh, has been recognised as a 2024 highly ranked scholar by ScholarGPS, a globally respected platform for evaluating academic excellence.This coveted recognition places Prof Khaiwal among the top 0.05% of scholars worldwide, reflecting his exceptional contributions to public health,
environmental monitoring
, climate change, and
air pollution
research.According to the ScholarGPS 2024 global rankings, Khaiwal ranks 1st in North India, 21st worldwide in environmental monitoring, 16th in air pollution, 36th in pollution, 40th in general public health and 174th in public health.Khaiwal's pioneering research has significantly influenced environmental and health policy, addressing some of the most pressing global challenges.
His work has helped shape national strategies to combat air pollution and climate-related health risks, fostering collaboration between scientific, environmental, and public health sectors.With over 170 peer-reviewed publications, more than 17,000 citations, and an impressive h-index of 61, Khaiwal is widely regarded as one of India's leading environmental health scientists.
His earlier recognition by Stanford University as being among the top 1% of global environmental scientists — with a #1 rank in India and #130 globally in meteorology and atmospheric science — further underscores his academic impact.Throughout his career, Khaiwal has received numerous national and international accolades, including finalist, Elsevier NASI-SCOPUS Young Scientist Award (2014); International Visitor Leadership Program (IVLP) fellowship by the US Department of State (2018); PN Raju Oration Award, ICMR (2019) and Presidential Award, Indian Association of Preventive & Social Medicine (IAPSM) (2021).ScholarGPS evaluates more than 30 million scholars globally, ranking them across 14 fields, 177 disciplines, and over 350,000 specialties based on objective, quantitative indicators such as publication volume, citation impact, and h-index.Khaiwal's latest recognition is not only a personal achievement but also a testament to PGIMER's commitment to promoting impactful, world-class research in public health and environmental sciences.PGIMER congratulated Khaiwal on this prestigious honour and reaffirmed its dedication to advancing research that drives positive change in public health and environmental sustainability.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
31-05-2025
- Hindustan Times
Chandigarh: A single hookah puff equal to 30-40 of cigarette, warns PGIMER
One puff of hookah is equivalent to taking 30-40 cigarettes puffs in one go, experts at Post Graduate Institute of Medical Education and Research (PGIMER) have warned. Though serving hookah in any commercial establishments is banned in the tricity, raids have revealed easy availability of hookah and other tobacco products in the market, with many bars and clubs serving them to customers. On the eve of 37th World No Tobacco Day, Dr Sonu Goel, director, Resource Centre for Tobacco Control (RCTC) and professor at department of community medicine and public health, PGIMER, spoke on this year's theme: 'Unmasking the appeal: Exposing industry tactics on tobacco and nicotine products'. Goel explained that the effects of tobacco on the body can be seen within 20 minutes of its consumption, including hiked pulse rate. 'Tobacco is behind 70% chronic obstructive pulmonary disease (COPD) cases, a lung condition causing respiratory issues. Of all oral cancer cases, 80% are caused by tobacco consumption, and it is responsible for around 50% of pulmonary cardiac consumers are four times more prone to getting severe tuberculosis than non-users,' he further cautioned. He highlighted that despite these dangers, companies often did not carry hazard warnings for tobacco products other than cigarettes. According to the Global Adult Tobacco survey, the prevalence of tobacco use in India is 28.6% and 11% in Chandigarh. Every year in India, 13 lakh preventable deaths are occurring due to tobacco, he shared. Heated tobacco products Goel said that as per the provisions of Cigarettes and Other Tobacco Products Act (COTPA), companies must carry hazard warning on the cover of tobacco products. He pointed out that companies, however, were not issuing this warning on heated tobacco products (HTP) as they claim that the COTPA covers only cigarettes not HTP. He explained that unlike cigarettes, HTPs were consumed by heating rather than burning, which also had detrimental effects on the body. 'Slim cigarettes, vapes, just as dangerous Dr Sonu Goel said despite the tobacco content in a slim cigarette being equivalent to any other cigarette, they were packaged and marketed in a more appealing way. He highlighted that with a slim look, choice of colours and flavours, these cigarettes were given the impression of being less harmful than regular cigarettes, which is not the case. Goel added that filtered cigarettes did not filter harmful substances, but only the amount of tar to some extent, and a user consumed equal content of harmful chemicals from filtered and non-filtered cigarettes. Similarly, e-cigarettes, commonly known as vapes, which also contain tobacco and nicotine, were marketed and sold by companies as a way to combat tobacco addiction. However, given the presence of high levels of nicotine in them, use of vapes can also lead to serious health issues, including cardiac and lung problems. 'E-cigarettes are also banned under the Prohibition of Electronic Cigarettes Act, 2019. However, due to poor enforcement, vapes are easily available in the market,' pointed out Dr Goel.
India Today
30-05-2025
- India Today
How robotic surgery is transforming women's health in India
As India observes Women's Health Month, India Today spoke with leading gynaecologists and surgeons behind a landmark multi-institutional study titled 'Trends in Gynecological Robotic Surgery in India: A Real-World Scenario', which is shedding light on how robotic-assisted surgery (RAS) is transforming gynaecological care nationwide. Conducted across five premier tertiary hospitals—Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bangalore), Narayana Hrudayalaya (Bangalore), and Tata Memorial Hospital (Mumbai)—the study showcases how RAS is driving better outcomes for women undergoing surgery for both benign and malignant by data spanning over a decade, the study reflects how innovation in surgical technology is not just enhancing recovery but redefining access and quality in women's healthcare across to the study, more than 70% of all robotic gynaecological surgeries were performed in just the last five years, indicating rapid adoption and growing trust in the technology. This reflects a broader shift in surgical practice, where precision, minimal invasiveness, and faster recovery are becoming central priorities, especially for women who often juggle health with multiple PRECISION FOR COMPLEX GYNAECOLOGICAL CONDITIONS "Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City and one of the lead authors of the study, underlines the key value of robotic-assisted surgery: precision. 'Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced outcomes across a wide range of cases,' she said. This precision is particularly important in surgeries involving fertility preservation, such as myomectomy—the removal of fibroids while keeping the uterus RECOVERY, LESS BLOOD LOSS, FEWER COMPLICATIONSadvertisementAcross hospitals, the data echoed similar global findings: robotic-assisted procedures resulted in reduced blood loss, shorter hospital stays, and quicker recoveries. These improvements are especially valuable in the Indian healthcare context, where many patients travel long distances for treatment. 'We were able to keep blood loss low and recovery times short—even for large fibroids or complex cases,' said Dr Sinha, who also serves as the Founder-President of the Association of Gynaecological Robotic RESULTS REGARDLESS OF BODY TYPEThe study also found that BMI (Body Mass Index) had no significant impact on surgical outcomes, meaning that RAS can be equally effective across a wide range of body types. Additionally, improved surgical workflows—like shorter docking times as teams gained experience—also contributed to more efficient and safe CONDITIONS TREATED USING ROBOTIC SURGERYAmong the most common conditions treated using RAS wereFibroids (Myomas)EndometriosisAdenomyosisVault prolapseOvarian cystsThese often require intricate dissection and suturing, making robotic assistance especially beneficial. 'Advanced robotic platforms like da Vinci give us better visualisation and control, which makes a real difference in such complex surgeries,' explained Dr Subhas C. Saha, Professor at TOWARDS ACCESSIBLE AND AFFORDABLE RASDespite the benefits, cost and insurance coverage remain major hurdles. However, surgeons are working on refining procedures to lower costs, such as using fewer robotic arms and adopting multifunctional tools. 'There is a strong case for insurers to expand coverage,' Dr Saha added. 'More streamlined reimbursement policies can help ensure that advanced care becomes accessible to a broader population.'advertisementAs robotic surgery continues to evolve and become more mainstream, it is poised to play a pivotal role in the future of women's healthcare in India. Its benefits—faster recovery, fewer complications, and precision—align with the needs of today's patients. With improved access and affordability, robotic-assisted gynaecological surgery could soon become the standard of care, delivering better outcomes for women across the country.
Hans India
30-05-2025
- Hans India
Robotic-assisted surgery steadily transforming gynaecological care: Study
Bengaluru: A study released to coincide with Women's Health Month, is shedding light on how robotic-assisted surgery (RAS) is steadily transforming gynaecological care across the country. May month is observed as Women's Health Month worldwide, to focus on raising awareness about women's health issues and encouraging women to prioritise their physical, mental, and emotional well-being. 'Women's Health Month is a time to reflect on how surgical technology innovations like the da Vinci robotic technology are enhancing healthcare outcomes for women,' said Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City, Hyderabad, one of the surgeons who oversaw the study. The multi-institutional study, 'Trends in Gynaecological Robotic Surgery in India: A Real-World Scenario', was conducted across five tertiary care hospitals -- Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bengaluru), Narayana Health (Bengaluru), and Tata Memorial Hospital (Mumbai). It analysed the data of surgeries performed using the da Vinci technology over a decade. The study documents a significant rise in the use of robotic surgery for both benign and malignant conditions and is significant for its implications on access, recovery, and surgical outcomes for women. 'Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced precision and improved outcomes across a wide range of cases,' said Dr Sinha, who is also the Founder-President of Association of Gynecological Robotic Surgeons. According to her, over 70 per cent of robotic gynaecological procedures took place in the final five years, indicating a strong upward trajectory. 'We have seen that with robotic procedures, women often spend less time in the hospital and experience fewer complications related to blood loss,' said Dr Vanita Jain, Head of Obstetrics and Gynaecology at PGIMER, Chandigarh, who was also part of the study. She noted that it is not just about using new technology. 'It is about making recovery more manageable, especially for women who are balancing responsibilities at home and work,' added Dr Jain. The study found that fibroids were the most common benign indication for robotic surgery, followed by endometriosis, adenomyosis, vault prolapse, and ovarian cysts. These conditions, said the doctors, often require careful dissection and suturing, particularly when fertility preservation is important. 'Myomectomy, or the removal of fibroids while preserving the uterus, especially calls for such precision,' explained Dr Subhas C Saha, Professor, Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, another key facilitator of the study. 'Advanced robotic systems like the da Vinci platform offer us better visualisation and manoeuvrability, which can make a real difference in these challenging cases,' he added. While more public and private insurers are beginning to include robotic-assisted surgery (RAS) in their coverage, the study highlights that there is still room to improve affordability and access. To optimise value and accessibility, surgeons are refining techniques -- using fewer robotic arms and incorporating multifunctional instruments -- to reduce costs while still delivering high-quality care and better patient outcomes. 'Given the clear benefits demonstrated in studies like this, there is a strong case for insurance payers to further expand coverage for robotic-assisted surgery. Broader, streamlined reimbursement support can help ensure more women across India have access to advanced surgical options,' Dr Saha added.
